Search papers, labs, and topics across Lattice.
NVIDIAAI-Driven Genomic Medicine and Drug Discovery LabChildren鈥檚 Hospital of China Medical UniversityChina Medical UniversityChina Medical University HospitalDepartment of Medical Laboratory Science and BiotechnologyRIKENSchool of Chinese MedicineJul 13, 2026arXiv:2607.11084The NVAITC AI Scientist (NAIS) is an end-to-end governed research system designed to facilitate scientific workflows in biomedical environments, ensuring compliance with data privacy regulations. In a hypertension genome-wide association study (GWAS) involving over 286,000 individuals, NAIS successfully orchestrated the research process, from cohort extraction to evidence generation, while enabling human oversight to refine phenotypic definitions. The system not only reproduced known hypertension loci with high statistical significance but also demonstrated its versatility by supporting a secondary prediction workflow for drug-induced liver injury, achieving an AUC of 0.842 with a multimodal graph neural network.
NAIS can autonomously conduct complex biomedical research while maintaining rigorous governance and human oversight, achieving results on par with traditional expert-led studies.
Agentic research systems are emerging as a new paradigm for coordinating scientific workflows beyond isolated model inference, code generation, or statistical analysis. However, deployment in institutional biomedical environments requires governed mechanisms for research planning, data access, workflow orchestration, evidence tracking, reproducibility, and human oversight. We present NVAITC AI Scientist (NAIS), a governed end-to-end agentic research system designed to support domain-general scientific workflows while keeping protected data within institutional privacy boundaries. NAIS integrates proposal review, execution planning, governed computational routing, reproducible workflow orchestration, evidence generation, and scientist-in-the-loop oversight. We validate NAIS in a real-world hypertension genome-wide association study (GWAS) using hospital-linked genotype and electronic health record (EHR) data from 286,422 individuals under an aggregate-only data policy. The agent planned cohort extraction, orchestrated GWAS execution, generated quality-control summaries, and drafted publication-oriented outputs. Human-AI review identified phenotype discrepancies and enabled iterative refinement of the hypertension definition. After reconciliation, the agent-orchestrated GWAS reproduced established hypertension loci, including FGF5, ATP2B1, CNNM2, FTO, and GRB14, with the strongest signal at FGF5 reaching $-\log_{10}(p) \sim 70$. As a secondary demonstration, NAIS also supported a drug-induced liver injury prediction workflow, achieving a multimodal graph neural network AUC of 0.842. These results demonstrate that governed agentic research systems can support scalable AI-assisted biomedical discovery while producing outputs comparable to expert-led workflows.
